CEO John Romano highlighted that Tronox delivered solid results despite macroeconomic challenges, with strong TiO2 ...

In an era of mounting fiscal uncertainty marked by flat, or even downward trending, net revenue at hospitals, the need for cost reduction has never been greater. Yet, many cost reduction efforts fail.

CEO John Romano highlighted a 12% sequential increase in TiO2 volumes, supported by European growth due to anti-dumping duties finalized in January. North America showed seasonal improvement, while ...

Discover key Q3 2025 insights for Dana Incorporated (DAN), including margin growth, cost savings, and future outlook.

Hexagon says it largely offset tariff impact in Q2 Flags just over 2 mln euro hit, vs April estimate of up to 15 mln euros Operating profit beats consensus despite 10% drop Plans cost improvement ...

Regulated information Revenue of €445 million, 3.8% lower LFL year on year due to softer market demand, and 3.7% up versus Q2 on volume growth driven by contract gains;Adj. EBITDA margin at 11.4%, 0.6 ...

Wide-moat Givaudan GIVN reported mixed first-half 2023 results, with lower-than-expected sales growth but a stronger-than-expected EBITDA margin. Like-for-like sales growth was 2.4% (versus 3.4% in ...